In recognition of National Caregivers Month, this episode explores the vital role of those who support individuals living with vision loss—whether family members, professionals, or volunteers. Our guests will discuss the emotional, physical, and financial challenges care partners face and share practical resources to help support them.

Stem cell research is offering new possibilities for treating age-related macular degeneration (AMD), a leading cause of vision loss. In this Macular Chat, Dr. Jeffrey Stern and Dr. Sally Temple, Principal Investigators and Co-Founders of the Neural Stem Cell Institute, will explain what stem cells are, share the latest updates from clinical trials such as Luxa Biotechnology’s RPESC-RPE transplantation, and discuss the safety, outcomes, and future potential of stem cell therapies. They will also address what these advances mean for patients and caregivers today, what clinical trials are available, and what timelines might look like for making these treatments more widely accessible.

Geographic atrophy (GA), an advanced form of age-related macular degeneration, can lead to irreversible vision loss. New long-term data are offering hope that treatment can slow this decline and help preserve sight. Join Dr. Sara Fard, a retina specialist at Illinois Retina Associates, as she explains the benefits of sustained GA treatment, including slowing the rate of vision loss, protecting retinal tissue, and supporting daily visual function. 

Ever wonder how Macular Degeneration Research identifies and supports the most promising scientific studies around the world? We recently awarded $3.8 million to researchers advancing bold ideas to better understand, prevent, and treat macular degeneration. In this episode of Macular Chats, Dr. Diane Bovenkamp highlights several of this year’s groundbreaking projects and explain how they’re driving progress in early detection, risk reduction, new treatments—and ultimately, a cure.

Can a simple vitamin or supplement help protect your sight? In this Macular Chats episode, we explore what current science tells us about nutritional approaches to support eye health, particularly in the context of age-related changes in the retina. Join Dr. Brian McKay and Dr. Murray Brilliant for a conversation about the widely used AREDS2 nutrient formula, as well as exciting new research into L-DOPA, a naturally occurring compound that may offer a stronger role for maintaining retinal health.

This Mental Health Awareness Month, join psychologist Ed McDaniel for an honest conversation about the emotional impact of being diagnosed with age-related macular degeneration (AMD) and/or geographic atrophy (GA). Drawing from both his professional expertise and personal experience, Ed will share strategies for coping with anxiety, grief, and loss of independence—and how to start important conversations about mental health with your eye doctor. Learn about resources that can help you feel less alone.

Join us for a special discussion on clinical trials for macular degeneration. Experts from Genentech will provide an overview of the company’s work in age-related macular degeneration (AMD) and geographic atrophy, including the role of clinical trials and how they work. They will also share details about an upcoming clinical trial for geographic atrophy, an advanced form of dry AMD, and what potential participants can expect.

Join us for a conversation about light therapy and macular degeneration, where we’ll explore how different types of light—blue, red, and sunlight—affect the retina, the science behind light therapy, and the newly approved Valeda red light therapy. Plus, we’ll answer listener questions about seasonal affective disorder (SAD) lights, red light therapy for early-stage AMD, and more. Bring your questions to ask our guest expert!

With two FDA-approved treatments now available for geographic atrophy, an advanced form of dry age-related macular degeneration, we’ll explore how to navigate treatment options, engage in shared decision-making with your healthcare team, and maximize your eye health. February is Low Vision Awareness Month, so we’ll also discuss support options for those living with vision loss.

Join us for an in-depth discussion on the latest developments in wet age-related macular degeneration treatment. We’re partnering with the American Society of Retina Specialists (ASRS) to bring you an overview of current treatment options, the impact of the Avastin shortage, and alternative treatments. We will also explore advocacy efforts by ASRS and the American Academy of Ophthalmology to address these issues.

This Macular Chat episode will cover practical tips for maintaining quality of life with low vision. From adaptive activities to resources like large print books, there are resources to help you live well.